Found 18 matching trials
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
EARLY_PHASE1The purpose of this study is to assess the safety, tolerability, and effica...
Location
Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology
Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
EARLY_PHASE1This is an early exploratory phase, single arm, non-randomized, open label,...
Location
Department of Rheumatology, Ren Ji Hospital South Campus, School of Medicine, Shanghai JiaoTong University
Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus
PHASE1This is a phase I, single arm, non-randomized, open label, treatment study ...
Location
The First Affiliated Hospital,College of Medicine, Zhejiang University
This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
EARLY_PHASE1This is an early exploratory study to assess the tolerability and safety of...
Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology
An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
PHASE1This is a single-arm, open-label and early exploratory clinical study, with...
Location
Huashan Hospital, affiliated to Fudan University, Shanghai,
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
PHASE1This is a Phase 1b open-label, multicenter, non-randomized study of GC012F,...
GC012F in Patients With Autoimmune Diseases
EARLY_PHASE1This is an open-label, early exploratory main clinical study to evaluate th...
Location
Multiple Locations
Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients
PHASE1This is a single-arm, single-center, open-label clinical study to evaluate ...
Location
Shanghai Changzheng Hospital
An Open-label Study of GC012F in Rheumatoid Arthritis.
EARLY_PHASE1This is An Open-label Study to Evaluate the Safety and Efficacy of GC012F i...
Location
Institute of Hematology & Blood Diseases Hospital, China
A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus
PHASE1This is a single-arm, open-label, multicenter, phase 1/2 clinical study to ...
Status
Active Not Recruiting